Ad
related to: fda orphan drug grant- Contact Us
Call + Email
24/7 Live Chat
- Verify: FDA Registration
Free Tool To Verify That Your US
FDA Registration Is Currently Valid
- FDA Registration
Quick & Easy
Register Your Business
- FDA MoCRA Online Training
8-Course Online Training Package On
Introduction: FDA MoCRA Regulations
- Contact Us
Search results
Kazia Granted 180-Day Extension by Nasdaq to Meet the Minimum Bid Price Requirement - Kazia...
Benzinga· 4 days agoKazia Therapeutics Limited KZIA (Kazia or the company) received a letter on May 22, 2024 from Nasdaq notifying the Company that, while the Company has not regained compliance with the Minimum ...
Q1 2024 Biomx Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 5 days agoIn January this year, we were granted Orphan Drug Designation by the FDA for BX004. More recently, in April, we presented positive safety ...
Sobi North America Gets FDA Fast Track Designation for Rheumatic Disease Complication Treatment
Morningstar· 3 days agoBy Ben Glickman Sobi North America said it had received fast track designation from U.S. regulators for its potential treatment for Macrophage Activation Syndrome, a complication of rheumatic diseases. The Waltham, Mass.-based affiliate
Calliditas Q1 report, January - March 2024
FOX 59 Indianapolis· 4 days agoNet sales amounted to SEK 295.5 million, of which TARPEYO® net sales amounted to SEK 278.3 million, for the three months ended March 31, 2024. For the...
Gilead (GILD) Announces Positive Interim Results on PBC Drug
Zacks via Yahoo Finance· 7 days agoGilead Sciences (GILD) experimental candidate, seladelpar, demonstrates significant improvements in...
Precigen to Host a Webcast on June 3rd to Detail Pivotal Study Results of PRGN-2012 in Recurrent...
FOX21 Colorado Springs· 4 days agoPrecigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced that the Company ...
Mabwell Announces 9MW2821 Clinical Data and Latest Progress to be presented at 2024 ASCO Annual...
FOX 59 Indianapolis· 3 days agoMabwell (688062.SH), an innovation-driven biopharmaceutical company, announced the data and latest...
Transcenta Debuts Encouraging Phase II Data from First-line Triple Combo Trial of Osemitamab...
FOX 23 News Albany· 4 days agoPhase II results reveal median PFS of 12.6 months in patients with CLDN18.2 high or medium...